Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Diabetic Kidney Disease in Rats by Inhibiting Apoptosis...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Nephrology

Background:

• Diabetic kidney disease (DKD) is a major complication of diabetes.
• Bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exo) have shown anti-inflammatory effects.
• The therapeutic potential of BMSC-Exo for DKD requires further investigation.

Purpose of the Study:

• To investigate the therapeutic effect of BMSC-Exo on DKD in a rat model.
• To elucidate the underlying mechanisms of BMSC-Exo in treating DKD.

Main Methods:

• A DKD rat model was established using streptozotocin and a high-fat diet.
• BMSC-Exo were administered weekly via tail vein injection for 12 weeks.
• Kidney pathology, apoptosis, inflammation markers (TNF-α, NF-κB), and biochemical parameters (GLU, Cr, BUN) were assessed.

Main Results:

• BMSC-Exo treatment significantly alleviated renal structural damage and reduced apoptotic cells in diabetic rats.
• BMSC-Exo modulated apoptosis-related proteins (Bax, Cleaved Caspase 9, Cleaved caspase 3).
• BMSC-Exo treatment decreased TNF-α and NF-κB (p65) expression, and improved GLU, Cr, and BUN levels.

Conclusions:

• BMSC-Exo demonstrate a therapeutic effect on DKD.
• BMSC-Exo may exert their protective effects by inhibiting renal cell apoptosis and inflammation.